Ironwood Pharmaceuticals Inc (IRWD)
3.44
+0.10
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
3.42
-0.02
(-0.58%)
After-Hours: 20:00
Ironwood Pharmaceuticals Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2023 | 2.341 |
| June 28, 2023 | 2.321 |
| June 27, 2023 | 2.325 |
| June 26, 2023 | 2.338 |
| June 23, 2023 | 2.402 |
| June 22, 2023 | 2.418 |
| June 21, 2023 | 2.380 |
| June 20, 2023 | 2.367 |
| June 16, 2023 | 2.413 |
| June 15, 2023 | 2.424 |
| June 14, 2023 | 2.428 |
| June 13, 2023 | 2.424 |
| June 12, 2023 | 2.510 |
| June 09, 2023 | 2.510 |
| June 08, 2023 | 2.549 |
| June 07, 2023 | 2.530 |
| June 06, 2023 | 2.477 |
| June 05, 2023 | 2.424 |
| June 02, 2023 | 2.424 |
| June 01, 2023 | 2.391 |
| May 31, 2023 | 2.391 |
| May 30, 2023 | 2.362 |
| May 26, 2023 | 2.376 |
| May 25, 2023 | 2.358 |
| May 24, 2023 | 2.376 |
| Date | Value |
|---|---|
| May 23, 2023 | 2.411 |
| May 22, 2023 | 2.384 |
| May 19, 2023 | 2.301 |
| May 18, 2023 | 2.246 |
| May 17, 2023 | 2.244 |
| May 16, 2023 | 2.220 |
| May 15, 2023 | 2.314 |
| May 12, 2023 | 2.226 |
| May 11, 2023 | 2.255 |
| May 10, 2023 | 2.29 |
| May 09, 2023 | 2.255 |
| May 08, 2023 | 2.310 |
| May 05, 2023 | 2.345 |
| May 04, 2023 | 2.325 |
| May 03, 2023 | 2.310 |
| May 02, 2023 | 2.292 |
| May 01, 2023 | 2.345 |
| April 28, 2023 | 2.288 |
| April 27, 2023 | 2.29 |
| April 26, 2023 | 2.29 |
| April 25, 2023 | 2.314 |
| April 24, 2023 | 2.323 |
| April 21, 2023 | 2.362 |
| April 20, 2023 | 2.349 |
| April 19, 2023 | 2.384 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.220
Minimum
May 16 2023
330.69
Maximum
Dec 14 2020
33.62
Average
3.408
Median
Aug 18 2022
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.121 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.360 |
| Theriva Biologics Inc | 0.1446 |
| Oragenics Inc | 2.254 |
Price to Book Value Related Metrics
| PS Ratio | 1.438 |
| Price to Free Cash Flow | 4.396 |
| Price | 3.44 |
| Earnings Yield | -0.87% |
| Market Cap | 550.50M |
| Operating PE Ratio | 5.070 |
| Normalized PE Ratio | 312.76 |